Galectin Therapeutics Inc. (GALT) SEC filings
GALT SEC filings moved a median of -1.37% by the close. GALT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the GALT overview →
60 measured GALT SEC filing events.
Where these GALT SEC filings landedvs 60 measured GALT SEC filing reactions
| Middle 50% of GALT SEC filing reactions | -7.14% to +2.18% |
|---|---|
| Median reaction (to close) | -1.37% |
| Measured reactions | 60 |
Point-in-time · zero look-ahead
Half of the 60 GALT SEC filing events with a measured close landed between -7.14% and +2.18%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form ARS GALECTIN THERAPEUTICS For: Dec 31 | SEC filing · Form ARS | -0.26% | -3.91% | |
| Form DEF 14A GALECTIN THERAPEUTICS For: Dec 03 | SEC filing · Form DEF | -0.26% | -3.91% | |
| Form DEFA14A GALECTIN THERAPEUTICS | SEC filing · Form DEFA14A | -0.26% | -3.91% | |
| Form PRE 14A GALECTIN THERAPEUTICS For: Dec 03 | SEC filing · Form PRE | -0.38% | -0.38% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Jun 30 | SEC filing · Form 10-Q | -4.57% | -1.71% | |
| Form 8-K GALECTIN THERAPEUTICS For: Aug 14 | SEC filing · Form 8-K | -4.57% | -1.71% | |
| Form 8-K GALECTIN THERAPEUTICS For: Jul 31 | SEC filing · Form 8-K | +3.38% | +0.84% | |
| Form 8-K GALECTIN THERAPEUTICS For: Jun 23 | SEC filing · Form 8-K | +7.93% | +15.13% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Mar 31 | SEC filing · Form 10-Q | -1.91% | -8.05% | |
| Form 8-K GALECTIN THERAPEUTICS For: May 15 | SEC filing · Form 8-K | -1.91% | -8.05% | |
| Form EFFECT GALECTIN THERAPEUTICS | SEC filing · Form EFFECT | -0.44% | +2.62% | |
| Form 10-K GALECTIN THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | +2.35% | +9.41% | |
| Form 8-K GALECTIN THERAPEUTICS For: Mar 31 | SEC filing · Form 8-K | +2.35% | +9.41% | |
| Form S-3 GALECTIN THERAPEUTICS | SEC filing · Form S-3 | +1.08% | -3.60% | |
| Form 8-K GALECTIN THERAPEUTICS For: Mar 12 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K GALECTIN THERAPEUTICS For: Jan 16 | SEC filing · Form 8-K | -0.90% | +11.36% | |
| Form 8-K GALECTIN THERAPEUTICS For: Jan 10 | SEC filing · Form 8-K | -1.56% | -4.06% | |
| Form 8-K GALECTIN THERAPEUTICS For: Dec 19 | SEC filing · Form 8-K | -8.84% | -5.60% | |
| Form 8-K GALECTIN THERAPEUTICS For: Dec 03 | SEC filing · Form 8-K | +3.16% | +5.80% | |
| Form 8-K GALECTIN THERAPEUTICS For: Dec 03 | SEC filing · Form 8-K | — | +2.43% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | +2.94% | +8.04% | |
| Form 8-K GALECTIN THERAPEUTICS For: Nov 14 | SEC filing · Form 8-K | +2.94% | +8.04% | |
| Form 8-K GALECTIN THERAPEUTICS For: Nov 10 | SEC filing · Form 8-K | +5.65% | -3.70% | |
| Form ARS GALECTIN THERAPEUTICS For: Dec 31 | SEC filing · Form ARS | -0.57% | -7.92% | |
| Form DEF 14A GALECTIN THERAPEUTICS For: Dec 03 | SEC filing · Form DEF | -0.57% | -7.92% | |
| Form DEFA14A GALECTIN THERAPEUTICS | SEC filing · Form DEFA14A | -0.57% | -7.92% | |
| Form 8-K GALECTIN THERAPEUTICS For: Sep 08 | SEC filing · Form 8-K | -0.81% | -0.64% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Jun 30 | SEC filing · Form 10-Q | +1.90% | +1.90% | |
| Form 8-K GALECTIN THERAPEUTICS For: Aug 14 | SEC filing · Form 8-K | +1.90% | +1.90% | |
| Form 8-K GALECTIN THERAPEUTICS For: Jul 08 | SEC filing · Form 8-K | +1.40% | +4.65% | |
| Form 8-K GALECTIN THERAPEUTICS For: Jun 16 | SEC filing · Form 8-K | +1.46% | -6.58% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.54% | |
| Form 8-K GALECTIN THERAPEUTICS For: May 15 | SEC filing · Form 8-K | +0.00% | +1.54% | |
| Form 8-K GALECTIN THERAPEUTICS For: May 12 | SEC filing · Form 8-K | -4.08% | -5.44% | |
| Form 10-K GALECTIN THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | -10.64% | -13.47% | |
| Form 8-K GALECTIN THERAPEUTICS For: Mar 31 | SEC filing · Form 8-K | -10.64% | -13.47% | |
| Form 8-K GALECTIN THERAPEUTICS For: Mar 05 | SEC filing · Form 8-K | +0.00% | -2.48% | |
| Form 8-K GALECTIN THERAPEUTICS For: Feb 18 | SEC filing · Form 8-K | -1.99% | +1.32% | |
| Form 8-K GALECTIN THERAPEUTICS For: Jan 23 | SEC filing · Form 8-K | +0.82% | +0.82% | |
| Form 8-K GALECTIN THERAPEUTICS For: Jan 23 | SEC filing · Form 8-K | +1.60% | +1.65% | |
| Form 8-K GALECTIN THERAPEUTICS For: Jan 13 | SEC filing · Form 8-K | -0.18% | +0.91% | |
| Form 8-K GALECTIN THERAPEUTICS For: Dec 20 | SEC filing · Form 8-K | +19.49% | -11.86% | |
| Form ARS GALECTIN THERAPEUTICS For: Dec 31 | SEC filing · Form ARS | -6.79% | -7.14% | |
| Form DEF 14A GALECTIN THERAPEUTICS For: Jan 23 | SEC filing · Form DEF | -6.79% | -7.14% | |
| Form DEFA14A GALECTIN THERAPEUTICS | SEC filing · Form DEFA14A | -6.79% | -7.14% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -3.85% | |
| Form 8-K GALECTIN THERAPEUTICS For: Nov 14 | SEC filing · Form 8-K | +0.00% | -3.85% | |
| Form 8-K GALECTIN THERAPEUTICS For: Sep 09 | SEC filing · Form 8-K | -0.41% | +5.58% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +6.13% | |
| Form 8-K GALECTIN THERAPEUTICS For: Aug 13 | SEC filing · Form 8-K | +0.00% | +6.13% | |
| Form 8-K GALECTIN THERAPEUTICS For: Jul 26 | SEC filing · Form 8-K | +0.00% | -9.88% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Mar 31 | SEC filing · Form 10-Q | +3.60% | +10.07% | |
| Form 8-K GALECTIN THERAPEUTICS For: May 15 | SEC filing · Form 8-K | +3.60% | +10.07% | |
| Form 10-K GALECTIN THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | -5.44% | +2.09% | |
| Form 8-K GALECTIN THERAPEUTICS For: Mar 29 | SEC filing · Form 8-K | -5.44% | +2.09% | |
| Form 8-K GALECTIN THERAPEUTICS For: Dec 07 | SEC filing · Form 8-K | +0.00% | -7.82% | |
| Form 8-K GALECTIN THERAPEUTICS For: Dec 07 | SEC filing · Form 8-K | -0.44% | -1.03% | |
| Form 10-Q GALECTIN THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | -4.29% | -7.14% | |
| Form 8-K GALECTIN THERAPEUTICS For: Aug 14 | SEC filing · Form 8-K | -4.29% | -7.14% | |
| Form 8-K/A GALECTIN THERAPEUTICS For: Aug 14 | SEC filing · Form 8-K | -4.29% | -7.14% |
Keep exploring
More GALT: earnings → · analyst actions → · GALT overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NeuroOne Medical Technologies Corporation (NMTC) | 310 | -0.19% | 41% |
| SI-BONE, Inc. (SIBN) | 310 | +0.14% | 56% |
| MENLO THERAPEUTICS INC COMMON (MNLO) | 308 | 0.00% | 49% |
| Syros Pharmaceuticals, Inc. (SYRS) | 307 | +0.51% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.